These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
673 related articles for article (PubMed ID: 25085455)
1. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study. Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455 [TBL] [Abstract][Full Text] [Related]
2. Sci-Sat AM: Brachy - 08: MRI-guided planning and maximum achievable HR-CTV doses in cervix brachytherapy. Menon G; Sloboda R; Ghosh S; Dundas G; Pearcey R; Huang F Med Phys; 2012 Jul; 39(7Part4):4646. PubMed ID: 28516636 [TBL] [Abstract][Full Text] [Related]
3. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer. Sharma M; Fields EC; Todor DA Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424 [TBL] [Abstract][Full Text] [Related]
4. Point A vs. HR-CTV D Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173 [TBL] [Abstract][Full Text] [Related]
5. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer. Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732 [TBL] [Abstract][Full Text] [Related]
7. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients. Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510 [TBL] [Abstract][Full Text] [Related]
8. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring. Eskander RN; Scanderbeg D; Saenz CC; Brown M; Yashar C Int J Gynecol Cancer; 2010 Jan; 20(1):47-53. PubMed ID: 20130502 [TBL] [Abstract][Full Text] [Related]
9. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept. Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784 [TBL] [Abstract][Full Text] [Related]
10. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims? Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694 [TBL] [Abstract][Full Text] [Related]
11. Dosimetric comparison of 3-dimensional planning techniques using an intravaginal multichannel balloon applicator for high-dose-rate gynecologic brachytherapy. Park SJ; Chung M; Demanes DJ; Banerjee R; Steinberg M; Kamrava M Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):840-6. PubMed ID: 24138921 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of offline adaptive planning techniques in image-guided brachytherapy of cervical cancer. Liu H; Kinard J; Maurer J; Shang Q; Vanderstraeten C; Hayes L; Sintay B; Wiant D J Appl Clin Med Phys; 2018 Nov; 19(6):316-322. PubMed ID: 30284370 [TBL] [Abstract][Full Text] [Related]
13. Comparison of dosimetric parameters in the treatment planning of magnetic resonance imaging-based intracavitary image-guided adaptive brachytherapy with and without optimization using the central shielding technique. Nishikawa R; Yoshida K; Ebina Y; Omoteda M; Miyawaki D; Ishihara T; Ejima Y; Akasaka H; Satoh H; Kyotani K; Takahashi S; Sasaki R J Radiat Res; 2018 May; 59(3):316-326. PubMed ID: 29518234 [TBL] [Abstract][Full Text] [Related]
14. Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: comparison between tandem-ovoid applicator users. Nomden CN; de Leeuw AA; Van Limbergen E; de Brabandere M; Nulens A; Nout RA; Laman M; Ketelaars M; Lutgens L; Reniers B; Jürgenliemk-Schulz IM Radiother Oncol; 2013 Apr; 107(1):82-7. PubMed ID: 23127774 [TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix. Zwahlen D; Jezioranski J; Chan P; Haider MA; Cho YB; Yeung I; Levin W; Manchul L; Fyles A; Milosevic M Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1157-64. PubMed ID: 19101097 [TBL] [Abstract][Full Text] [Related]
16. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer. Jürgenliemk-Schulz IM; Tersteeg RJ; Roesink JM; Bijmolt S; Nomden CN; Moerland MA; de Leeuw AA Radiother Oncol; 2009 Nov; 93(2):322-30. PubMed ID: 19748695 [TBL] [Abstract][Full Text] [Related]
17. Dose escalation in brachytherapy for cervical cancer: impact on (or increased need for) MRI-guided plan optimisation. Paton AM; Chalmers KE; Coomber H; Cameron AL Br J Radiol; 2012 Dec; 85(1020):e1249-55. PubMed ID: 23175490 [TBL] [Abstract][Full Text] [Related]